Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
SANOFI Stock Analysis
Views
Red Flags
Positive
Analysts have been raising forward EPS estimates
High and stable operating margin
Low Debt to Equity, not much change from last year
Consistently pays dividend
Company is net cash
Negative
Expensive and at same valuation levels as industry median P/E
Weak price momentum
Low revenue growth and lower than median growth of industry
Low EPS growth and lower than median growth of industry
Neutral
High ROE but declining trend
Company's earnings are of moderate quality
Moderate dividend yield
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
SANOFI Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
SANOFI Bulk, Block & Insider Trades
SANOFI Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Bonus
Stock split
Others
Bonus(1 new shares for 1 existing shares)Bonus issue 1 for every existing equity share held Ex-date: 23rd Sep 1994
Stock split(1 : 10)Check from the stock trading price. Ex-date: 18th Nov 1991
Demerger (DEM)"As part of Demerger each shareholder entitled to receive 1 common share of Sanofi Consumer Healthcare India Limited for every 1 common share held." Ex-date: 13th Jun 2024 Announced on: 10th May 2023
Company Profile
Sanofi India Limited is an India-based company, which is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The Company produces pharmaceutical formulations, dosage forms and offer a range of medicines across various therapeutic areas. Its product portfolio is focused... Read More
Key personnel
Mr. Aditya NarayanD
Independent Non-Executive Chairman of the Board
Mr. Rachid AyariD
Chief Financial Officer, Whole Time Director
Mr. Haresh Vala
Compliance Officer, Company Secretary
Mr. Deepak AroraD
Managing Director, Additional Director
Mahadev GawadeD
Whole-Time Director and Site Director-Goa
Mr. Nitin Arora
India Partnerships Lead
Mr. N. Suresh Babu
Sales & Customer Engagement Head - Diabetes
Mr. Bratin Bag
Senior Director - Ethics and Business Integrity, South Asia
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Sanofi India Ltd.?
The current share price of Sanofi India Ltd. is ₹ 4,123.02 as of 09 Jan 2026.
What is the PE ratio of Sanofi India Ltd.?
The Price-to-Earnings (PE) ratio of Sanofi India Ltd. is 26.65 as of the latest financial data.
What is the ROE and ROCE of Sanofi India Ltd.?
Sanofi India Ltd. has a Return on Equity (ROE) of 49.43% and a Return on Capital Employed (ROCE) of 61.93% as per the latest financial reports.
What is the market cap of Sanofi India Ltd.?
The market capitalization of Sanofi India Ltd. stands at ₹ 9,495.73 Cr.
What is the dividend yield of Sanofi India Ltd.?
The dividend yield of Sanofi India Ltd. is 2.84% based on the current market price.
What is the RSI of Sanofi India Ltd.?
The Relative Strength Index (RSI) of Sanofi India Ltd. is 40.79.
What is the FII and DII holding in Sanofi India Ltd.?
Foreign Institutional Investors (FII) hold 5.57% and Domestic Institutional Investors (DII) hold 22.28% of Sanofi India Ltd. shares.
What sector does Sanofi India Ltd. belong to?
Sanofi India Ltd. operates in the Healthcare sector.
What is the beta of Sanofi India Ltd. stock?
The beta of Sanofi India Ltd. stock is 0.52, indicating its volatility relative to the broader market.
